Authors' Reply: "Risk Reduction With Buprenorphine-Naloxone and Methadone: Patient's Choice"

被引:0
|
作者
Woody, George [1 ,2 ]
Bruce, Douglas [3 ]
Korthuis, P. Todd [4 ]
Chhatre, Sumedha [1 ,2 ]
Hillhouse, Maureen [5 ]
Jacobs, Petra [2 ]
Sorensen, James [6 ]
Saxon, Andrew J. [7 ]
Poole, Sabrina [1 ]
Metzger, David [1 ,2 ]
Ling, Walter [5 ]
机构
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Treatment Res Inst, Philadelphia, PA USA
[3] Yale Univ, Sch Med, New Haven, CT USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA
关键词
D O I
10.1097/QAI.0000000000000344
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:E142 / E143
页数:3
相关论文
共 50 条
  • [1] Equal HIV Risk Reduction with Buprenorphine-Naloxone or Methadone
    Woody, George E.
    Bruce, Douglas
    Korthuis, P. Todd
    Chhatre, Sumedha
    Hillhouse, Maureen
    Sorensen, James L.
    Saxon, Andrew J.
    Jacobs, Petra
    Metzger, David S.
    Poole, Sabrina
    Ling, Walter
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S155 - S155
  • [2] HIV Risk Reduction With Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial
    Woody, George
    Bruce, Douglas
    Korthuis, P. Todd
    Chhatre, Sumedha
    Hillhouse, Maureen
    Jacobs, Petra
    Sorenson, James
    Saxon, Andrew
    Poole, Sabrina
    Metzger, David
    Ling, Walter
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S337 - S338
  • [3] HIV Risk Reduction With Buprenorphine-Naloxone or Methadone: Findings From a Randomized Trial
    Woody, George E.
    Bruce, Douglas
    Korthuis, P. Todd
    Chhatre, Sumedha
    Poole, Sabrina
    Hillhouse, Maureen
    Jacobs, Petra
    Sorensen, James
    Saxon, Andrew J.
    Metzger, David
    Ling, Walter
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 66 (03) : 288 - 293
  • [4] A comparison of methadone and buprenorphine-naloxone as opioid substitution therapy: the patient perspective in NHS Lanarkshire
    Hill, Duncan R.
    Conroy, Stephen
    Afzai, Afreen
    Lang, Debbie
    Steele, Siobhan
    Campbell, Derna
    [J]. JOURNAL OF SUBSTANCE USE, 2015, 20 (03) : 168 - 177
  • [5] Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
    Kanervo, Minna M.
    Tupola, Sarimari J.
    Nikkola, Eeva M.
    Rantakari, Krista M.
    Kahila, Hanna K.
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102 (03) : 313 - 322
  • [6] Assessment of Drug-Drug Interactions between Daclatasvir and Methadone or Buprenorphine-Naloxone
    Garimella, T.
    Wang, R.
    Luo, W. -L.
    Wastall, P.
    Kandoussi, H.
    DeMicco, M.
    Bruce, R. D.
    Hwang, C.
    Bertz, R.
    Bifano, M.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) : 5503 - 5510
  • [7] Primary care management of opioid use disorders Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava, Anita
    Kahan, Meldon
    Nader, Maya
    [J]. CANADIAN FAMILY PHYSICIAN, 2017, 63 (03) : 200 - 205
  • [8] Buprenorphine versus Methadone in Pregnancy The authors reply
    Suarez, Elizabeth A.
    Huybrechts, Krista F.
    Bateman, Brian T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (10): : 957 - 958
  • [9] Inpatient Transition from Methadone to Buprenorphine-Naloxone Using a Microdosing Strategy in a Postoperative Cancer Patient: A Case Report
    Kim, Min Ji
    Walker, Hayley
    Clark, Matthew
    Reddy, Akhila
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2024,
  • [10] Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxone
    Perez de Los Cobos, Jose
    Alcaraz, Saul
    Sinol, Nuria
    Gonzalez-Saiz, Francisco
    Vergara-Moragues, Esperanza
    Trujols, Joan
    Zambrano, Salvador
    Fonseca, Francina
    Torrens, Marta
    Bordas, Jordi
    Gonzalvo, Begona
    Moreno, Jose
    Morozova, Larina
    Trevino, Lara
    Fabregas, Joan
    Llebot, Sandra
    Moreno, Dolors
    Yuguero, Lara
    Blanco, Xose Ramon
    Manzano, Esperanza
    Marco, Andres
    da Silva, Antonio
    Ribalta, Elisa
    Sanz, Pedro
    Maria Vazquez, Jose
    Bruguera, Anna Ma
    Manuel Cruz, Cristo
    Barral, Carmen
    Grau-Lopez, Lara
    Perez, Jesus
    Roncero, Carlos
    Grau, Montserrat
    Conde, Manuel M.
    Dorado, Maria Luisa
    Orengo, Teresa
    Gonzalez, Pilar
    Ochando, Beatriz
    Ripoll, Carmen
    Sanchez, Amparo
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 212